Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study
Alexander Thomas Elford,
Maria Bishara,
Nikolas Plevris
et al.
Abstract:BackgroundUpadacitinib is a Janus kinase inhibitor, which has recently been approved for treating Crohn’s disease. There are limited real-world studies on the outcomes of upadacitinib in Crohn’s disease.ObjectiveOur aim was to evaluate the outcomes of upadacitinib in a real-world Crohn’s disease cohort.MethodsWe conducted a retrospective, multicentre, cohort study over a 2-year period across National Health Service (NHS) Lothian and Royal Devon University Healthcare NHS Foundation Trust. The primary outcome wa… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.